BRIEF published on 01/22/2026 at 06:45, 7 months 30 days ago Galenica AG Sees Record Sales Growth to Over CHF 4 Billion Financial Performance Sales Growth Galenica Pharmacy Expansion Diagnostics Introduction
PRESS RELEASE published on 01/22/2026 at 06:40, 7 months 30 days ago Galenica continues to grow: sales increase to over CHF 4 billion Galenica reports sales growth to over CHF 4 billion in 2025, driven by strong demand for prescription drugs and new 'Diagnostics' area. EBIT guidance and dividend expectations confirmed Sales Growth Galenica Diagnostics Prescription Drugs CHF 4 Billion
BRIEF published on 12/16/2025 at 14:00, 9 months 5 days ago Galenica expands its digital presence with the acquisition of Puravita Acquisition DIGITAL Galenica Puravita Drugstores
BRIEF published on 12/16/2025 at 14:00, 9 months 5 days ago Galenica Expands Digital Footprint with Puravita Acquisition Galenica Pharmacy Market Digital Expansion Puravita Online Offering
BRIEF published on 11/10/2025 at 18:00, 10 months 11 days ago Galenica Successfully Places CHF 250 Million Bond Long-term Financing SIX Swiss Exchange Bond Placement Galenica AG CHF 250 Million
PRESS RELEASE published on 11/10/2025 at 17:55, 10 months 11 days ago Galenica successfully places a bond of over CHF 250 million Galenica successfully places a CHF 250 million bond, reducing short-term liabilities and securing long-term financing. Proceeds used for Labor Team Group acquisition and general corporate purposes Acquisition Financing Bond Swiss Exchange Galenica
BRIEF published on 10/23/2025 at 06:45, 10 months 29 days ago Galenica AG to continue its sustained growth in 2025 Growth Galenica Pharmacy Drugs Labor Team
PRESS RELEASE published on 10/23/2025 at 06:40, 10 months 29 days ago Galenica remains on growth track Galenica Group reports 4.7% sales growth in Q3 2025 driven by prescription drugs and dietary supplements. Acquisition of Labor Team boosts expectations for sales and EBIT1 growth Sales Growth Dietary Supplements Galenica Prescription Drugs Labor Team
BRIEF published on 10/21/2025 at 08:00, 11 months ago Galenica Unveils Innovative Pharmacy Concept to Meet Evolving Needs Customer Experience Healthcare Digital Integration Galenica AG Pharmacy Concept
PRESS RELEASE published on 10/21/2025 at 07:55, 11 months ago Galenica strengthens basic care with new pharmacy concept Galenica tests new pharmacy concept focusing on consultations and customer experience at Amavita pharmacy in Zurich's Glattzentrum. Launch aims to reshape future pharmacies Customer Experience Galenica Pharmacy Concept Consultations Amavita
Published on 09/21/2026 at 15:45, 5 hours 3 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 6 hours 28 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 6 hours 43 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 6 hours 48 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 7 hours 3 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 20:34, 13 minutes ago BRANICKS Group AG: Regular interest payment on EUR 400 million bond to be made as scheduled – Completion of maturity extension imminent
Published on 09/21/2026 at 18:00, 2 hours 48 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 17:45, 3 hours 3 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 3 hours 3 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 3 hours 47 minutes ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 18:19, 2 hours 29 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 2 hours 46 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 3 hours 2 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 07:00, 13 hours 48 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
